Clearstead Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Buy |
849
+791
| +1,364% | +$137K | ﹤0.01% | 958 |
|
|
2025
Q1 | $9.04K | Hold |
58
| – | – | ﹤0.01% | 1622 |
|
|
2024
Q4 | $7.99K | Sell |
58
-1,085
| -95% | -$149K | ﹤0.01% | 1630 |
|
|
2024
Q3 | $171K | Sell |
1,143
-21
| -2% | -$3.14K | ﹤0.01% | 902 |
|
|
2024
Q2 | $159K | Buy |
1,164
+109
| +10% | +$14.9K | ﹤0.01% | 886 |
|
|
2024
Q1 | $139K | Buy |
1,055
+140
| +15% | +$18.5K | 0.01% | 530 |
|
|
2023
Q4 | $115K | Sell |
915
-775
| -46% | -$97.6K | 0.01% | 557 |
|
|
2023
Q3 | $158K | Buy |
1,690
+529
| +46% | +$49.5K | ﹤0.01% | 623 |
|
|
2023
Q2 | $104K | Buy |
1,161
+541
| +87% | +$48.3K | 0.01% | 572 |
|
|
2023
Q1 | $66.5K | Buy |
+620
| New | +$66.5K | ﹤0.01% | 596 |
|